Industry Uses Ebola Funding Request To Make Case For Consistent MCM Support

The “guaranteed marketplace” for medical countermeasures stopped at the end of fiscal 2013 when long-term funding ran out for key programs aimed at developing and procuring these products, the Biotechnology Industry Organization said in asking appropriators to stabilize funding authorized under the Pandemic and All-Hazards Preparedness Reauthorization Act in addition to granting the administration's emergency funding request for action on the Ebola outbreak. The Senate Appropriations Committee Wednesday (Nov. 12) held a hearing to discuss the administration's response to the...